Table of Contents
Chapter 1 Methodology and Scope
1.1 Research Methodology
1.2 Research Assumptions
1.2.1 Estimates And Forecast Timeline
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 Gvr’s Internal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.4 Information Or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
Chapter 2 Executive Summary
2.1 Market Snapshot
2.2 Segment Snapshot
2.3 Competitive Landscape Snapshot
Chapter 3 Market Variables, Trends, & Scope
3.1 Parent Market Analysis
3.2 Market Dynamics
3.2.1 Market Driver Analysis
3.2.1.1 Growing Academic And Industrial Interest In mRNA Technology
3.2.1.2 Advantages Of mRNA Vaccines
3.2.1.3 Increasing Funding For mRNA Research
3.2.2 Market Restraint Analysis
3.2.2.1 Nonexistence Of Effective Government Regulations For mRNA – Based Product Approvals
3.2.2.2 High Cost Of mRNA Synthesis Raw Materials
3.2.3 Market Challange Analysis
3.2.3.1 Lack Of Long – Lasting And Affordable Manufacturing Processes
3.3 Penetration &Growth Prospect Mapping
3.4 mRNA Synthesis Raw Materials Market – Porter’s Analysis
3.5 mRNA Synthesis Raw Materials Market – Swot Analysis
3.6 Covid – 19 Impact Analysis
Chapter 4 Type Business Analysis
4.1 mRNA Synthesis Raw Materials Market – Type Movement Analysis
4.2 Capping Agents
4.2.1 Global Capping Agents Market, 2018 – 2030 (USD Million)
4.3 Nucleotides
4.3.1 Global Nucleotides Market, 2018 – 2030 (USD Million)
4.4 Plasmid Dna
4.4.1 Global Plasmid Dna Market, 2018 – 2030 (USD Million)
4.5 Others
4.5.1 Global Other Types Market, 2018 – 2030 (USD Million)
Chapter 5 Application Business Analysis
5.1 mRNA Synthesis Raw Materials Market – Application Movement Analysis
5.2 Therapeutics Production
5.2.1 Global Therapeutics Production Market, 2018 – 2030 (USD Million)
5.3 Vaccine Production
5.3.1 Global Vaccine Production Market, 2018 – 2030 (USD Million)
5.4 Others
5.4.1 Global Other Applications Market, 2018 – 2030 (USD Million)
Chapter 6 End – User Business Analysis
6.1 mRNA Synthesis Raw Materials Market – End User Movement Analysis
6.2 Biopharmaceutical & Pharmaceutical Companies
6.2.1 Global Biopharmaceutical & Pharmaceutical Companies, 2018 – 2030 (USD Million)
6.3 Cros & Cmos
6.3.1 Global Cros & Cmos, 2018 – 2030 (USD Million)
6.4 Academic And Research Institutions
6.4.1 Global Academic And Research Institutions, 2018 – 2030 (USD Million)
Chapter 7 Regional Business Analysis
7.1 mRNA Synthesis Raw Materials Market: Regional Movement Analysis
7.2 North America
7.2.1 Swot Analysis
7.2.1.1 North America mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.2.2 U.S.
7.2.2.1 Key Country Dynamics
7.2.2.2 Competitive Scenario
7.2.2.3 Regulatory Framework
7.2.2.4 U.S. mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.2.3 Canada
7.2.3.1 Key country dynamics
7.2.3.2 Competitive scenario
7.2.3.3 Regulatory framework
7.2.3.4 Canada mRNA synthesis raw materials market, 2018 – 2030 (USD Million)
7.3 Europe
7.3.1 Swot Analysis
7.3.1.1 Europe mRNA Synthesis Raw Materials Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.3.2 Germany
7.3.2.1 Key Country Dynamics
7.3.2.2 Competitive Scenario
7.3.2.3 Regulatory Framework
7.3.2.4 Germany mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.3.3 U.K.
7.3.3.1 Key Country Dynamics
7.3.3.2 Competitive Scenario
7.3.3.3 Regulatory Framework
7.3.3.4 Uk mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.3.4 France
7.3.4.1 Key Country Dynamics
7.3.4.2 Competitive Scenario
7.3.4.3 Regulatory Framework
7.3.4.4 France mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.3.5 Italy
7.3.5.1 Key Country Dynamics
7.3.5.2 Competitive Scenario
7.3.5.3 Regulatory Framework
7.3.5.5 Italy mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.3.6 Spain
7.3.6.1 Key Country Dynamics
7.3.6.2 Competitive Scenario
7.3.6.3 Regulatory Framework
7.3.6.4 Spain mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.3.7 Denmark
7.3.7.1 Key Country Dynamics
7.3.7.2 Competitive Scenario
7.3.7.3 Regulatory Framework
7.3.7.4 Denmark mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.3.8 Sweden
7.3.8.1 Key Country Dynamics
7.3.8.2 Competitive Scenario
7.3.8.3 Regulatory Framework
7.3.8.4 Sweden mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.3.9 Norway
7.3.9.1 Key country dynamics
7.3.9.2 Competitive scenario
7.3.9.3 Regulatory framework
7.3.9.4 Norway mRNA synthesis raw materials market, 2018 – 2030 (USD Million)
7.4 Asia Pacific
7.4.1 Swot Analysis
7.4.1.1 Asia Pacific mRNA Synthesis Raw Materials, 2018 – 2030 (USD Million)
7.4.2 Japan
7.4.2.1 Key Country Dynamics
7.4.2.2 Competitive Scenario
7.4.2.3 Regulatory Framework
7.4.2.4 Japan mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.4.3 China
7.4.3.1 Key Country Dynamics
7.4.3.2 Competitive Scenario
7.4.3.3 Regulatory Framework
7.4.3.4 China mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.4.4 India
7.4.4.1 Key Country Dynamics
7.4.4.2 Competitive Scenario
7.4.4.3 Regulatory Framework
7.4.4.4 India mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.4.5 Australia
7.4.5.1 Key Country Dynamics
7.4.5.2 Competitive Scenario
7.4.5.3 Regulatory Framework
7.4.5.4 Australia mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.4.6 South Korea
7.4.6.1 Key Country Dynamics
7.4.6.2 Competitive Scenario
7.4.6.3 Regulatory Framework
7.4.6.4 South Korea mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.4.7 Thailand
7.4.7.1 Key country dynamics
7.4.7.2 Competitive scenario
7.4.7.3 Regulatory framework
7.4.7.4 Thailand mRNA synthesis raw materials market, 2018 – 2030 (USD Million)
7.5 Latin America
7.5.1 Swot Analysis
7.5.1.1 Latin America mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.5.2 Brazil
7.5.2.1 Key Country Dynamics
7.5.2.2 Competitive Scenario
7.5.2.3 Regulatory Framework
7.5.2.4 Brazil mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.5.3 Mexico
7.5.3.1 Key Country Dynamics
7.5.3.2 Competitive Scenario
7.5.3.3 Regulatory Framework
7.5.3.4 Mexico mRNA Synthesis Raw Materials Market, 2018 – 2030 (USD Million)
7.5.4 Argentina
7.5.4.1 Key country dynamics
7.5.4.2 Competitive scenario
7.5.4.3 Regulatory framework
7.5.4.4 Argentina mRNA synthesis raw materials market, 2018 – 2030 (USD Million)
7.6 Middle East & Africa
7.6.1 Swot Analysis
7.6.1.1 Mea mRNA Synthesis Raw Materials Market Estimates And Forecast, 2018 – 2030 (USD Million)
7.6.2 South Africa
7.6.2.1 Key country dynamics
7.6.2.2 Competitive scenario
7.6.2.3 Regulatory framework
7.6.2.4 South Africa mRNA synthesis raw materials market estimates and forecast, 2018 – 2030 (USD Million)
7.6.3 Saudi Arabia
7.6.3.1 Key country dynamics
7.6.3.2 Competitive scenario
7.6.3.3 Regulatory framework
7.6.3.4 Saudi Arabia mRNA synthesis raw materials market estimates and forecast, 2018 – 2030 (USD Million)
7.6.4 UAE
7.6.4.1 Key country dynamics
7.6.4.2 Competitive scenario
7.6.4.3 Regulatory framework
7.6.4.4 UAE mRNA synthesis raw materials market estimates and forecast, 2018 – 2030 (USD Million)
7.6.5 KUWAIT
7.6.5.1 Key country dynamics
7.6.5.2 Competitive scenario
7.6.5.3 Regulatory framework
7.6.5.4 Kuwait mRNA synthesis raw materials market estimates and forecast, 2018 – 2030 (USD Million)
Chapter 8 Competitive Landscape
8.1 Participant’s Overview
8.1.1 F. Hoffmann – La Roche Ltd.
8.1.2 Jena Bioscience Gmbh
8.1.3 Merck KGaA
8.1.4 Yeasen Biotechnology (Shanghai) Co.,Ltd.
8.1.5 BOC Sciences
8.1.6 Thermo Fisher Scientific, Inc.
8.1.7 Maravai Lifesciences
8.1.8 New England Biolabs
8.1.9 Creative Biogene
8.1.10 Hongene
8.2 Financial Performance
8.3 Participant Categorization
8.3.1 Market Leaders
8.3.1.1 mRNA Synthesis Raw Materials Market Share Analysis, 2022
8.3.2 Strategy Mapping
8.3.2.1 Expansion
8.3.2.2 Acquisition
8.3.2.3 Collaborations
8.3.2.4 Product/service launch
8.3.2.5 Partnerships
8.3.2.6 Others
